SGLT2 inhibitors and amputations in the US FDA Adverse Event Reporting System

标题
SGLT2 inhibitors and amputations in the US FDA Adverse Event Reporting System
作者
关键词
-
出版物
Lancet Diabetes & Endocrinology
Volume 5, Issue 9, Pages 680-681
出版商
Elsevier BV
发表日期
2017-07-19
DOI
10.1016/s2213-8587(17)30257-7

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started